The man who was later arrested was at the home, and he showed them a detached garage where police said they saw a large mushroom growing operation. The man, however, said the mushrooms were not illegal. He also declined to consent to a search of the home.
Authorities then got a search warrant and found what they called psilocybin-containing mushrooms in various stages of growth.
State police released photos showing dozens of bags allegedly containing mushrooms lined up outside the home as well as stacked on metal shelving throughout the home’s interior. The photos also show portable ventilators and other equipment.
After police entered the home with the warrant, the man “admitted to investigators that the mushrooms were in fact psilocybin, which is a Schedule 1 controlled substance,” state police said in a statement. “A Schedule 1 controlled substance is defined as drugs, substances and chemicals that are not currently accepted for medical use and have a high potential for abuse.”
The man posted $250,000 ($416,000) bail and was ordered to appear in state court in New Britain on November 16. Contact information for him could not be found in public records, and court records did not list a lawyer for him. Phone numbers listed in public records for several potential relatives of the man were no longer in service.
Oregon voters approved decriminalising small amounts of psychedelics in 2020, and separately were the first to approve the supervised use of psilocybin in a therapeutic setting. Two years later, Colorado voters passed a ballot measure to decriminalise psychedelic mushrooms and to create state-regulated centres where participants can experience the drug under supervision.
Last month, California Gov. Gavin Newsom vetoed a bill that would have decriminalized the possession and personal use of several hallucinogens, including psychedelic mushrooms, saying the state first needed regulated guidelines.
The federal Food and Drug Administration designated psilocybin as a “breakthrough therapy” for treatment-resistant depression in 2019 and recently published a draft guideline on using psychedelics in clinical trials. There has also been a shift in public opinion in support of the therapeutic use of psychedelics, including military veterans with trauma and other illnesses.